scispace - formally typeset
Open AccessJournal ArticleDOI

Isolation of rare cells from cell mixtures by dielectrophoresis

TLDR
The application of dielectrophoretic field‐flow fractionation to the isolation of circulating tumor cells from clinical blood specimens was studied and it is shown that the factor limiting isolation efficiency is cell–cell dielectric interactions.
Abstract
The application of dielectrophoretic field-flow fractionation (depFFF) to the isolation of circulating tumor cells (CTCs) from clinical blood specimens was studied using simulated cell mixtures of three different cultured tumor cell types with peripheral blood. The depFFF method can not only exploit intrinsic tumor cell properties so that labeling is unnecessary but can also deliver unmodified, viable tumor cells for culture and/or all types of molecular analysis. We investigated tumor cell recovery efficiency as a function of cell loading for a 25 mm wide x 300 mm long depFFF chamber. More than 90% of tumor cells were recovered for small samples but a larger chamber will be required if similarly high recovery efficiencies are to be realized for 10 mL blood specimens used CTC analysis in clinics. We show that the factor limiting isolation efficiency is cell-cell dielectric interactions and that isolation protocols should be completed within approximately 15 min in order to avoid changes in cell dielectric properties associated with ion leakage.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Circulating tumor cells: approaches to isolation and characterization

TL;DR: Improvements in technologies to yield purer CTC populations amenable to better cellular and molecular characterization will enable a broad range of clinical applications, including early detection of disease and the discovery of biomarkers to predict treatment responses and disease progression.
Journal ArticleDOI

Highly efficient capture of circulating tumor cells by using nanostructured silicon substrates with integrated chaotic micromixers.

TL;DR: In this paper, a variety of enrichment mechanisms such as immunomagnetic separation based on capture agent-labeled magnetic beads, microfluidics-based technologies that enhance cell-surface contacts, and microfilter devices that isolate CTCs based on size difference are proposed.
Journal ArticleDOI

Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA

TL;DR: Recent advances in technologies to analyze circulating tumor cells and circulating tumor DNA are setting the stage for real-time, noninvasive monitoring of cancer and providing novel insights into cancer evolution, invasion, and metastasis.
Journal ArticleDOI

Molecular analysis of circulating tumour cells—biology and biomarkers

TL;DR: How circulating tumour cells (CTCs), captured from a minimally invasive blood test—and readily amenable to serial sampling—have the potential to inform intratumour heterogeneity and tumour evolution is described, although it remains to be determined how useful this will be in the clinic.
Journal ArticleDOI

Circulating Tumor Cells and Circulating Tumor DNA

TL;DR: These methods allow the detection and characterization of early metastatic spread and will provide unique insights into the biology of metastatic progression of human tumors, including the effects of therapeutic interventions.
References
More filters
Journal ArticleDOI

Isolation of rare circulating tumour cells in cancer patients by microchip technology.

TL;DR: The CTC-chip successfully identified CTCs in the peripheral blood of patients with metastatic lung, prostate, pancreatic, breast and colon cancer in 115 of 116 samples, with a range of 5–1,281CTCs per ml and approximately 50% purity.
Book

Electromechanics of Particles

TL;DR: In this paper, a detailed account of the electromechanical interactions that govern the behaviour of small particles when an electric or magnetic field is present is presented, with numerous real-world examples.
Journal ArticleDOI

Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival

TL;DR: In this paper, the authors reported that ≥5 circulating tumor cells (CTC) in 7.5 mL blood at baseline and at first follow-up in 177 patients with metastatic breast cancer (MBC) were associated with poor clinical outcome.
Journal ArticleDOI

Circulating tumor cells (CTC) detection: clinical impact and future directions.

TL;DR: Cytopathological examination of CTC/CTM, sensitively enriched from blood, represents a potentially useful alternative and can now be employed in routine analyses as a specific diagnostic assay, and be tested in large, blind, multicenter clinical trials.
Related Papers (5)